Vaxneuvance Injection, Suspension
Product Images NDC 0006-4329

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Vaxneuvance (NDC 0006-4329). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Vaxneuvance 01)

Packaging label for VAXNEUVANCE, Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed, suspension for intramuscular injection. The carton contains 10 single-dose 0.5 mL syringes. The label includes storage instructions to refrigerate and identifies Merck Sharp & Dohme LLC as the manufacturer with NDC 0006-4329-03.*

FDA Label Image

Principal Display Panel (0.5 mL Syringe Label)

Packaging label for VAXNEUVANCE Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed, injection suspension for intramuscular use. The label indicates a pack of 10 single-dose 0.5 mL syringes and instructs refrigeration. The product is labeled for use in individuals 18 years and older and is manufactured by Merck Sharp & Dohme LLC. The NDC 0006-4329-03 and barcodes are also visible on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.